These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15296960)

  • 1. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration.
    Müller-Goymann CC
    Eur J Pharm Biopharm; 2004 Sep; 58(2):343-56. PubMed ID: 15296960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmaceutical applications of the zeta potential--use in characterization of colloidal drug carriers].
    Le Roy Boehm AL; Fessi H
    J Pharm Belg; 2000; 55(2):40-8. PubMed ID: 10842925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems.
    Uner M
    Pharmazie; 2006 May; 61(5):375-86. PubMed ID: 16724531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization of a reverse micellar solution after loading with different drugs.
    Friedrich I; Papantoniou I; Müller-Goymann CC
    Pharmazie; 2000 Oct; 55(10):755-8. PubMed ID: 11082837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured lipid carriers system: recent advances in drug delivery.
    Iqbal MA; Md S; Sahni JK; Baboota S; Dang S; Ali J
    J Drug Target; 2012 Dec; 20(10):813-30. PubMed ID: 22931500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems.
    Kuntsche J; Horst JC; Bunjes H
    Int J Pharm; 2011 Sep; 417(1-2):120-37. PubMed ID: 21310225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characterization of drug nanocarriers.
    Manaia EB; Abuçafy MP; Chiari-Andréo BG; Silva BL; Oshiro Junior JA; Chiavacci LA
    Int J Nanomedicine; 2017; 12():4991-5011. PubMed ID: 28761340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.
    Teeranachaideekul V; Souto EB; Junyaprasert VB; Müller RH
    Eur J Pharm Biopharm; 2007 Aug; 67(1):141-8. PubMed ID: 17346953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation, protection, and release of hydrophilic active components: potential and limitations of colloidal delivery systems.
    McClements DJ
    Adv Colloid Interface Sci; 2015 May; 219():27-53. PubMed ID: 25747522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Compared with colloidal silica and porous silica as baicalin solid dispersion carrier].
    Yan HM; Ding DM; Wang J; Sun E; Jia XB; Zhang ZH
    Zhongguo Zhong Yao Za Zhi; 2014 Jul; 39(13):2484-8. PubMed ID: 25276968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethosomes® and transfersomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders.
    Celia C; Cilurzo F; Trapasso E; Cosco D; Fresta M; Paolino D
    Biomed Microdevices; 2012 Feb; 14(1):119-30. PubMed ID: 21960035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid vesicles and other colloids as drug carriers on the skin.
    Cevc G
    Adv Drug Deliv Rev; 2004 Mar; 56(5):675-711. PubMed ID: 15019752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of solidified reverse micellar solutions (SRMS) and production development of SRMS-based nanosuspensions.
    Friedrich I; Müller-Goymann CC
    Eur J Pharm Biopharm; 2003 Jul; 56(1):111-9. PubMed ID: 12837489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin II receptor blocker.
    Hathout RM; Elshafeey AH
    Eur J Pharm Biopharm; 2012 Oct; 82(2):230-40. PubMed ID: 22820090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The formalism of fractal aggregation phenomena of colloidal drug delivery systems.
    Pippa N; Demetzos C; Danezis E
    J Liposome Res; 2012 Mar; 22(1):55-61. PubMed ID: 21774618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery.
    Xiong XB; Falamarzian A; Garg SM; Lavasanifar A
    J Control Release; 2011 Oct; 155(2):248-61. PubMed ID: 21621570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, and evaluation of physicochemical properties of different crystalline forms of ibuprofen.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):463-71. PubMed ID: 9876609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of submicron systems via optical methods.
    Haskell RJ
    J Pharm Sci; 1998 Feb; 87(2):125-9. PubMed ID: 9519143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel drug delivery system -- Drug crystallization encapsulated liquid crystal emulsion.
    Hu J; Ni Z; Zhu H; Li H; Chen Y; Shang Y; Chen D; Liu H
    Int J Pharm; 2021 Sep; 607():121007. PubMed ID: 34391854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.